Park Ha Biological Technology (BYAH) Payables (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Payables for 4 consecutive years, with $14775.0 the latest figure, recorded in Q2 2026.

• Quarterly Payables fell 12.07% year-over-year to $14775.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $14775.0 (down 12.07% YoY) and the FY2025 annual result came in at $12013.0, down 50.09% from the prior year.
• Payables improved to $14775.0 in Q2 2026 per BYAH's latest filing, from $12013.0 in the prior quarter.
• Over the last five years, Payables for BYAH reached as high as $197155.0 in Q4 2023 and fell as low as $12013.0 in Q4 2025.
• A 4-year average of $52963.0 and a median of $16803.0 in 2025 frame the typical range for Payables.
• Annual changes were most pronounced in 2024 — Payables slumped 87.79% — and 2026, when it decreased 12.07%.
• Year by year, Payables stood at $197155.0 in 2023, then sank by 87.79% to $24069.0 in 2024, then plunged by 50.09% to $12013.0 in 2025, then climbed by 22.99% to $14775.0 in 2026.
• According to Business Quant data, Payables over the past three periods registered $14775.0, $12013.0, and $16803.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.